Artal Group S.A. Kaleido Biosciences, Inc. Transaction History

Artal Group S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$5.02 - $8.87 $2.01 Million - $3.55 Million	-400,000 Reduced 44.42%	500,500 $2.51 Million
Q2 2019 Aug 09, 2019	SELL	$11.25 - $18.1 $527,838 - $849,233	-46,919 Reduced 4.95%	900,500 $10.4 Million
Q1 2019 May 10, 2019	BUY	$12.71 - $15.0 $12 Million - $14.2 Million	947,419 New	947,419 $13.7 Million

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.